Device for point-of-care nucleic acid purification and detection of HCV
ID:  CDC/NCHHSTP 057Type: BOTH
Overview

Topic

Device for point-of-care nucleic acid purification and detection of HCV

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2023

Topic Link

https://www.sbir.gov/node/2451765

Additional Information

https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view
Timeline
  1. 1
    Release Aug 25, 2023 12:00 AM
  2. 2
    Open Aug 25, 2023 12:00 AM
  3. 3
    Next Submission Due Nov 14, 2023 12:00 AM
  4. 4
    Close Nov 14, 2023 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for a Small Business Innovation Research (SBIR) contract. The topic of the solicitation is a "Device for point-of-care nucleic acid purification and detection of HCV".

The technology being solicited is a simple and inexpensive device that can perform nucleic acid extraction and detection workflows with minimal user intervention. This device would allow for the diagnosis of Hepatitis C virus (HCV) infection at the point of care, expanding access to HCV diagnostic testing.

The potential impact of this technology is significant, as HCV infection is a major global health problem and a leading cause of cirrhosis and liver cancer. The World Health Organization (WHO) has established elimination goals for HCV infection, and achieving these goals will require expanding access to HCV testing. Currently, HCV diagnostic testing methods have high costs, slow turnaround times, and need to be performed in a laboratory, leading to access problems and potential loss of patients to follow-up care.

The project duration for Phase I is up to 6 months, with a budget of up to $243,500. Phase II has a budget of up to $1,972,828 and a duration of up to 2 years. Only Phase I SBIR proposals will be accepted, and fast-track proposals and Phase I clinical trials will not be accepted. The anticipated number of awards is 1.

Proposals that exceed the budget or project duration listed above may not be funded. More information about the solicitation can be found on the grants.gov website (link: https://www.sbir.gov/node/2451765) and the sam.gov website (link: https://sam.gov/opp/aa72581c848947f0b61c15062e604862/view). The solicitation was released on August 25, 2023, and the application due date is November 14, 2023.

Files
No associated files provided.
Similar Opportunities
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and eliminate health disparities. The research should focus on identifying and addressing issues within clinical diagnostics that perpetuate health inequity. The projects may involve existing clinical diagnostics or propose new ones. Applicants are encouraged to consider social determinants of health during the development process and include input from relevant populations that experience health disparities. The funding opportunity accepts different types of projects, including those that address pigment variation in imaging devices, utilize equitable parameters instead of non-biological parameters like race, improve analytics or bioinformatics, develop clinical decision support tools, validate new technology, or further develop existing technology. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. For more information, including specific research objectives and areas of interest, interested parties can visit the solicitation agency URL provided.
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies, analytics or bioinformatics, clinical decision support tools, and pilot or small-scale projects. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. More information can be found on the grants.gov website.
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of novel tools and devices for animal research facilities and to support the care of animal models. The Office of Research Infrastructure Programs (ORIP) is encouraging applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects in this area. The goal of this solicitation is to improve animal welfare, ease the management of individual animals and animal colonies, and enhance the monitoring and control of environmental conditions that affect outcomes and reproducibility in animal model research. The variation of extrinsic factors between different animal facilities has been cited as a source of irreproducibility in animal research, and this solicitation aims to address this issue. The solicitation specifically calls for the development and implementation of novel tools and devices to monitor environmental conditions, identify pathogens and contaminants, and enable noninvasive or minimally invasive monitoring of animal behavior and bodily functions. The devices should be discreet, robust, easy to apply, and mobile. Additionally, the solicitation seeks new software that can combine data from different monitoring devices and be compatible with different data formats. The solicitation emphasizes the importance of innovation and encourages the adaptation of technologies from other fields to improve animal research. It applies to a broad range of animal models, including invertebrate and vertebrate animals, and excludes disease-specific devices, reagents, and experimental protocols. Examples of specific tools and devices that can be developed include portable software for managing and evaluating animal colonies, noninvasive tracking and monitoring technology, automated feeding systems, devices for drug delivery and measurement, improved systems for data collection and analysis, better phenotyping devices, improved holding and transfer devices, and enhanced air and water filters for animal facilities. The solicitation is open for applications until September 6, 2024, and applicants are advised to discuss their projects with the Scientific/Research contacts before submitting an application. More information can be found on the grants.gov website.
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the industrialization and translation of extracellular vesicles (EVs) for use in regenerative medicine. EVs are membrane-enclosed carriers of bioactive substances that are used for intercellular communication. This funding opportunity aims to support the development of novel EV-based therapeutic platforms for tissue and organ repair in regenerative medicine. The focus is on the production, manufacturing, and use of native or engineered EVs as therapeutics. The goal is to address challenges in the field and advance the translation of EVs into clinical applications. The funding opportunity is open to small business concerns and offers both Phase I and Phase II grants. The projects should focus on large-scale GMP grade production and manufacturing challenges associated with the use of EVs as therapeutics. The application due dates are June 6th of each year from 2023 to 2025. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/PA-files/PAR-23-267.html).
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for SBIR Phase IIB Bridge Awards to accelerate the development of cancer-relevant technologies toward commercialization. This funding opportunity aims to support small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards from any Federal agency. The goal is to assist applicants in pursuing the next milestone necessary to advance a promising product or service along a commercialization pathway. The focus is on cancer therapeutics, imaging technologies, diagnostics, prevention and control tools, and model systems for cancer research. The funding will prioritize projects that have secured substantial independent third-party investor funds and those that require approval from a Federal regulatory agency. The application due date is August 21, 2024, and more information can be found at the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-022.html).